EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neural Stem Cell‐Derived Extracellular Vesicles Improve CNS Delivery and Therapeutic Efficacy of Antisense Oligonucleotide in Amyotrophic Lateral Sclerosis

Yaochao Zheng iD, Taylor Jade Ellison iD, Robert Garrard iD, Jinghui Gao, Xinning Lai, Lin Lan, Jin Xie iD, Jie Jiang iD, Yao Yao iD

Journal of Extracellular Vesicles · 2026

DOI: 10.1002/jev2.70370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2026. Verfasst von Yaochao Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Bioscience Center, Department of Animal and Dairy Science, College of agricultural and environmental sciences, University of Georgia, At…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Extracellular Vesicles, Oligonucleotides, Antisense, Neural Stem Cells. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Department of Defense, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antisense oligonucleotides (ASOs) hold clinical promise for the treatment of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). Yet, their efficacy is constrained by the need for invasive delivery, poor central nervous system (CNS) penetration, inefficient cellular uptake and rapid clearance. Here, we developed neural stem cell‐derived extracellular vesicles (NSC‐EVs) as natural carriers to enhance CNS targeting and therapeutic efficacy of ASO‐based treatments for ALS. Using a passive loading method, therapeutic ASOs were efficiently associated with NSC‐EVs (NSC‐EV‐ASO). Compared with free ASOs, NSC‐EVs‐ ASOs exhibited markedly enhanced neuronal uptake in vitro and increased CNS accumulation and neuronal localization in vivo following intracerebroventricular, intranasal, or intravenous administration. Functionally, NSC‐EV‐ASOs reduced the mutant SOD1 protein expression and the pathogenic hexanucleotide repeats in the C9orf72 loci in ALS cellular models. In the ALS mouse model, intranasal administration of NSC‐EV‐ASOs more efficiently delayed disease onset, improved motor performance, preserved motor neurons and attenuated astrocyte activation during the study period compared with free ASOs. These findings provide proof‐of‐concept evidence supporting the potential of NSC‐EV as a promising platform that not only enhances CNS delivery of ASOs but also contributes to overall therapeutic activity, offering a synergistic strategy to advance nucleic acid therapeutics for ALS and potentially other neurological diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisExtracellular VesiclesOligonucleotides, AntisenseNeural Stem CellsCentral Nervous SystemAnimalsMiceHumansDisease Models, AnimalSuperoxide Dismutase-1Motor NeuronsMaleAdministration, Intranasal

Stichwörter der Autor:innen

amyotrophic lateral sclerosisantisense oligonucleotidedrug deliveryextracellular vesiclesneural stem cell

Substanzen

Oligonucleotides, AntisenseSuperoxide Dismutase-1

Autor:innen und Institutionen

  • Regenerative Bioscience Center, Department of Animal and Dairy Science, College of agricultural and environmental sciences, University of Georgia, Athens, Georgia, USA.
  • Department of Chemistry, University of Georgia, Athens, Georgia, USA.
  • Department of Cell Biology, Emory University, Atlanta, Georgia, USA.

ORCID-Profile: Yaochao Zheng, Taylor Jade Ellison, Robert Garrard, Jin Xie, Jie Jiang, Yao Yao

Förderung

  • NIA NIH HHS
  • Department of Defense
  • NIH HHS
  • U.S. Department of Defense
  • National Science Foundation
  • National Institutes of Health

Zitieren

APA

Zheng, Y., Ellison, T. J., Garrard, R., Gao, J., Lai, X., Lan, L., Xie, J., Jiang, J., & Yao, Y. (2026). Neural Stem Cell‐Derived Extracellular Vesicles Improve CNS Delivery and Therapeutic Efficacy of Antisense Oligonucleotide in Amyotrophic Lateral Sclerosis. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70370

Vancouver

Zheng Y, Ellison TJ, Garrard R, Gao J, Lai X, Lan L, et al. Neural Stem Cell‐Derived Extracellular Vesicles Improve CNS Delivery and Therapeutic Efficacy of Antisense Oligonucleotide in Amyotrophic Lateral Sclerosis. Journal of Extracellular Vesicles. 2026. doi:10.1002/jev2.70370

BibTeX
@article{Zheng2026,
  author = {Zheng, Yaochao and Ellison, Taylor Jade and Garrard, Robert and Gao, Jinghui and Lai, Xinning and Lan, Lin and Xie, Jin and Jiang, Jie and Yao, Yao},
  title = {Neural Stem Cell‐Derived Extracellular Vesicles Improve CNS Delivery and Therapeutic Efficacy of Antisense Oligonucleotide in Amyotrophic Lateral Sclerosis},
  journal = {Journal of Extracellular Vesicles},
  year = {2026},
  doi = {10.1002/jev2.70370}
}
Kostenlos starten →